Global X Genomics & Biotechnology ETF (GNOM)Health | Exchange Traded Fund | NasdaqGM
64.81 USD
-2.43
(-3.619%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 64.75 -0.06 (-0.057%) ⇩ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 1:08 a.m. EDT
The immediate outlook is bullish due to a powerful technical rebound. After languishing near 52-week lows for months, the fund has surged nearly 20% in just two weeks, breaking through key resistance levels and reclaiming the 55.69 fifty-day average. This momentum is confirmed by the options flow, where buyers are aggressively targeting upside moves while sellers hedge against a crash. However, this recovery is fragile; the asset remains trapped in a severe long-term downtrend, having lost over one-third of its value since 2019. While the recent price action suggests a potential bottoming process, the underlying business quality has not yet proven itself resilient enough to sustain a multi-year bull case, making this a high-risk, high-reward tactical play rather than a core holding. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.059227 |
| MSTL | 0.061817 |
| AutoARIMA | 0.061865 |
| AutoETS | 0.061866 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 11.89 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.027 |
| Excess Kurtosis | -0.11 |
As of Aug. 22, 2026, 1:08 a.m. EDT: Speculators are positioning defensively with heavy out-of-the-money put open interest at strikes significantly below current prices (34 and 36), suggesting a fear of a deep correction. Conversely, call activity is concentrated in the money at strikes near the current price (50 and 60), indicating traders are betting on a bounce or consolidation rather than a massive breakout. Implied volatility is elevated on the downside side relative to the upside, reflecting asymmetric risk pricing.
| Last Yield | 1yr Yield | 3yr Avg | 5yr Avg |
|---|---|---|---|
| 0.10% | 1.40% | 0.50% | 0.31% |
| Date | Dividend | Yield % |
|---|---|---|
| 2026-06-29 | 0.058 | 0.101541 |
| 2025-12-30 | 0.591 | 1.295768 |
| 2025-06-27 | 0.032 | 0.095238 |
| 2021-12-30 | 0.028 | 0.035035 |
| 2020-12-30 | 0.128 | 0.131959 |
| Attribute | Value |
|---|---|
| All Time High | 113.8 |
| All Time Low | 11.49 |
| Ask | 56.47 |
| Ask Size | 3 |
| Average Daily Volume10 Day | 31,190 |
| Average Daily Volume3 Month | 29,134 |
| Average Volume | 29,134 |
| Average Volume10Days | 31,190 |
| Beta3 Year | 1.62 |
| Bid | 55.77 |
| Bid Size | 3 |
| Category | Health |
| Crypto Tradeable | 0 |
| Currency | USD |
| Custom Price Alert Confidence | HIGH |
| Day High | 66.61 |
| Day Low | 64.73 |
| Dividend Yield | 1.19 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 57.73082 |
| Fifty Day Average Change | 7.075783 |
| Fifty Day Average Change Percent | 0.12256508 |
| Fifty Two Week Change Percent | 75.10673 |
| Fifty Two Week High | 68.0 |
| Fifty Two Week High Change | -3.1933975 |
| Fifty Two Week High Change Percent | -0.04696173 |
| Fifty Two Week Low | 36.0 |
| Fifty Two Week Low Change | 28.806602 |
| Fifty Two Week Low Change Percent | 0.8001834 |
| Fifty Two Week Range | 36.0 - 68.0 |
| First Trade Date Milliseconds | 1,554,903,000,000 |
| Five Year Average Return | -0.0663698 |
| Full Exchange Name | NasdaqGM |
| Fullday Change | -2.4334 |
| Fullday Change Percent | -3.61897 |
| Fullday Price | 64.75 |
| Fund Family | Global X Funds |
| Fund Inception Date | 1,554,422,400 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Has Pre Post Market Data | 1 |
| Language | en-US |
| Legal Type | Exchange Traded Fund |
| Long Business Summary | The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified. |
| Long Name | Global X Genomics & Biotechnology ETF |
| Market | us_market |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_605753422 |
| Nav Price | 67.06 |
| Net Assets | 79,648,416.0 |
| Net Expense Ratio | 0.5 |
| Open | 66.61 |
| Phone | +1 8884938631 |
| Post Market Change | -0.056602478 |
| Post Market Change Percent | -0.0873406 |
| Post Market Price | 64.75 |
| Post Market Time | 1,787,959,804 |
| Previous Close | 67.24 |
| Price Hint | 2 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | ETF |
| Region | US |
| Regular Market Change | -2.4333954 |
| Regular Market Change Percent | -3.6189702 |
| Regular Market Day High | 66.61 |
| Regular Market Day Low | 64.73 |
| Regular Market Day Range | 64.73 - 66.61 |
| Regular Market Open | 66.61 |
| Regular Market Previous Close | 67.24 |
| Regular Market Price | 64.8066 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 39,551 |
| Short Name | Global X Genomics & Biotechnolo |
| Source Interval | 15 |
| Symbol | GNOM |
| Three Year Average Return | 0.1554678 |
| Total Assets | 79,648,416 |
| Tradeable | 0 |
| Trailing Peg Ratio | None |
| Trailing Three Month Nav Returns | 20.27245 |
| Trailing Three Month Returns | 20.27245 |
| Triggerable | 1 |
| Two Hundred Day Average | 49.141624 |
| Two Hundred Day Average Change | 15.664978 |
| Two Hundred Day Average Change Percent | 0.31877208 |
| Type Disp | ETF |
| Volume | 39,551 |
| Yield | 0.0119 |
| Ytd Return | 19.53296 |